CAMP and colorectal cancer: As another mechanism, analysis of the 177 intracellular metabolites and 113 secretory metabolites of colorectal cancer cells showed considerable alteration in their metabolic profile (glycolysis, purine metabolism, and Krebs cycle) in FF/CAP18-treated cells in a dose-dependent manner (117).